Chemoinformaics analysis of Methyl 2-Furoate
| Molecular Weight | 126.111 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.063 | nRig | 6 |
| Exact Molecular Weight | 126.032 | nRing | 1 |
| Solubility: LogS | -1.529 | nHRing | 1 |
| Solubility: LogP | 1.112 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 16.4268 |
| nHD | 0 | BPOL | 10.3592 |
| QED | 0.528 |
| Synth | 1.803 |
| Natural Product Likeliness | -0.985 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.008 |
| CACO-2 | -4.342 |
| MDCK | 0.0000264 |
| BBB | 0.694 |
| PPB | 0.789505 |
| VDSS | 1.94 |
| FU | 0.339664 |
| CYP1A2-inh | 0.936 |
| CYP1A2-sub | 0.77 |
| CYP2c19-inh | 0.546 |
| CYP2c19-sub | 0.26 |
| CYP2c9-inh | 0.102 |
| CYP2c9-sub | 0.373 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.323 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.244 |
| CL | 11.561 |
| T12 | 0.884 |
| hERG | 0.107 |
| Ames | 0.124 |
| ROA | 0.836 |
| SkinSen | 0.134 |
| Carcinogencity | 0.756 |
| EI | 0.991 |
| Respiratory | 0.742 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.918019 |